As of 2026-01-03, the Relative Valuation of Gemina Laboratories Ltd (GLAB.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.06 CAD, the upside of Gemina Laboratories Ltd based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2025-12-31 | -3.60 |
| 2025-12-30 | -3.60 |
| 2025-12-29 | -5.99 |
| 2025-12-22 | -4.80 |
| 2025-12-10 | -7.79 |
| 2025-12-08 | -7.79 |
| 2025-12-05 | -13.19 |
| 2025-12-04 | -10.79 |
| 2025-12-01 | -11.99 |
| 2025-11-28 | -9.59 |
| 2025-11-26 | -14.39 |
| 2025-11-25 | -13.79 |
| 2025-11-07 | -23.98 |
| 2025-11-03 | -22.18 |
| 2025-10-29 | -23.68 |
| 2025-10-22 | -28.17 |
| 2025-10-10 | -26.97 |
| 2025-10-06 | -28.77 |